Amgen scraps experimental weight loss pill, moves forward with injection

The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023.Mario Tama | Getty ImagesAmgen on Thursday said it will stop developing its experimental weight loss pill and instead move forward with its injectable drug and other products in development for obesity.The announcement is...

Read more...

Stanley Black & Decker’s earnings beat fails to satisfy Wall Street. Here’s why we bought the dip

Stanley Black & Decker overcame a soft demand environment to deliver a top and bottom line beat Thursday, but the stock is falling because the toolmaker simply reiterated its guidance. That's a fate shared by home-improvement peers and many other companies this earnings season. We added to our position...

Read more...

Bausch Health investors are left in a holding pattern, overhangs remain unresolved

Bausch Health Companies on Tuesday morning reported first-quarter top- and bottom-line misses — putting embattled shares under pressure. Revenue for the three months ended in March increased 11% (about 8% organically) to $2.15 billion, a hair short of the Street estimate of $2.16 billion, according to LSEG. Adjusted EBITDA...

Read more...